CCNY Professor to Test Monoclonal Antibodies as Ovarian Cancer Diagnostic Reagent
MabCure Inc., (OTCBB:MBCI) a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents. The work will be performed in the laboratory of Professor Paul Gottlieb of The City College of New York’s Sophie Davis School of Biomedical Education.Read More »
The Y Chromosome: Junk or Jewel?
Dr. David C. Page, Bryson Professor of Biology at the Massachusetts Institute of Technology, will deliver the 2012 Louis Levine – Gabriella de Beer Lecture in Genetics at The City College of New York 5 p.m. Wednesday, March 28, 2012. He will speak in The Great Hall of Shepard Hall, 160 Convent Avenue, New York. The lecture, titled “Rethinking the Rotting Y Chromosome,” is free and open to the public. A reception will follow.Read More »
Could a NOSH-Aspirin-a-Day Keep Cancer Away?
The humble aspirin may soon have a new role. Scientists from The City College of New York have developed a new aspirin compound that has great promise to be not only an extremely potent cancer-fighter, but even safer than the classic medicine cabinet staple.Read More »
2nd Annual National Urban Health Conference Focuses on Urban Ecology Feb 23 – 26
The Greater Harlem Chamber of Commerce, along with the New York Academy of Medicine, Harlem Hospital, Emblem Health, Touro College and The City College of New York, is sponsoring the second annual National Urban Health Conference. The four-day event will take place from February 23rd to February 26th and will center on the theme of Urban Ecology.Read More »